首页> 美国卫生研究院文献>Innovations in Clinical Neuroscience >Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report
【2h】

Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report

机译:埃索佐匹克隆诱导的自杀性失眠症病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Eszopiclone is a benzodiazepine-like hypnotic that is commonly prescribed to treat insomnia. However, eszopiclone’s efficacy has been questionable in several clinical trials, and its pharmacologic profile makes its effects on sleep and behavior difficult to predict. We report a case demonstrating an instance of eszopiclone-induced parasomnia involving paranoia and a suicide attempt in a patient taking eszopiclone. We explore possible biochemical explanations examining the pharmacologic profile of eszopiclone and its potential for drug-drug interactions, especially with concomitant administration of monoaminergic medications such as antidepressants. Caution should be exercised when prescribing these medications, and evidence-based treatments for insomnia (e.g., cognitive behavioral therapy, biofeedback, sedating antidepressants) should be considered prior to sedative-hypnotic administration.
机译:Eszopiclone是一种苯二氮卓类催眠药,通常处方用于治疗失眠。但是,在许多临床试验中,依佐匹克隆的功效一直令人质疑,其药理作用使其难以预测对睡眠和行为的影响。我们报告了一起病例,该病例表明服用依佐匹克隆的患者发生了埃佐匹克隆的诱发的失眠,涉及妄想症和自杀企图。我们探索可能的生化解释,检查埃索匹克隆的药理作用及其潜在的药物相互作用,尤其是与单胺能药物(如抗抑郁药)同时给药。处方这些药物时应谨慎行事,在镇静催眠药给药前应考虑循证治疗失眠(例如认知行为疗法,生物反馈,镇静抗抑郁药)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号